Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Psychiatry Research
|
November 4, 2022
How to reap the benefits of language for psychiatry
Iris E Sommer, Janna N de Boer
Current Opinion in Psychiatry
|
February 9, 2021
Estrogens in schizophrenia: progress, current challenges and opportunities
Bodyl A Brand, Janna N de Boer, Iris E C Sommer
The Lancet. Psychiatry
|
February 26, 2022
Towards better care for women with schizophrenia-spectrum disorders
Bodyl A Brand, Janna N de Boer, Paola Dazzan, et al.
Current Opinion in Psychiatry
|
February 13, 2020
Anomalies in language as a biomarker for schizophrenia
Janna N de Boer, Sanne G Brederoo, Alban E Voppel, et al.
NPP - Digital Psychiatry and Neuroscience
|
June 10, 2026
Does ChatGPT need a psychiatrist? Similarities between human psychopathology and errors in large language models
Janna N de Boer, Silvia Ciampelli, Araya K Hailemariam, et al.
Schizophrenia Bulletin
|
October 28, 2022
Semantic and Acoustic Markers in Schizophrenia-Spectrum Disorders: A Combinatory Machine Learning Approach
Alban E Voppel, Janna N de Boer, Sanne G Brederoo, et al.
CNS & Neurological Disorders Drug Targets
|
December 28, 2021
Speech as a Biomarker for Depression
Sanne Koops, Sanne G Brederoo, Janna N de Boer, et al.
Scientific Reports
|
April 9, 2021
Fragmented sleep relates to hallucinations across perceptual modalities in the general population
Sanne G Brederoo, Janna N de Boer, Jacqueline de Vries, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
March 12, 2024
The experience of felt presence in a general population sample
Sanne G Brederoo, Ben Alderson-Day, Janna N de Boer, et al.
Schizophrenia Bulletin
|
April 28, 2023
The Direct and Long-Term Effects of Raloxifene as Adjunctive Treatment for Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Clinical Trial
Bodyl A Brand, Janna N de Boer, Machteld C Marcelis, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Psychiatry Research
|
November 4, 2022
How to reap the benefits of language for psychiatry
Iris E Sommer, Janna N de Boer
Current Opinion in Psychiatry
|
February 9, 2021
Estrogens in schizophrenia: progress, current challenges and opportunities
Bodyl A Brand, Janna N de Boer, Iris E C Sommer
The Lancet. Psychiatry
|
February 26, 2022
Towards better care for women with schizophrenia-spectrum disorders
Bodyl A Brand, Janna N de Boer, Paola Dazzan, et al.
Current Opinion in Psychiatry
|
February 13, 2020
Anomalies in language as a biomarker for schizophrenia
Janna N de Boer, Sanne G Brederoo, Alban E Voppel, et al.
NPP - Digital Psychiatry and Neuroscience
|
June 10, 2026
Does ChatGPT need a psychiatrist? Similarities between human psychopathology and errors in large language models
Janna N de Boer, Silvia Ciampelli, Araya K Hailemariam, et al.
Schizophrenia Bulletin
|
October 28, 2022
Semantic and Acoustic Markers in Schizophrenia-Spectrum Disorders: A Combinatory Machine Learning Approach
Alban E Voppel, Janna N de Boer, Sanne G Brederoo, et al.
CNS & Neurological Disorders Drug Targets
|
December 28, 2021
Speech as a Biomarker for Depression
Sanne Koops, Sanne G Brederoo, Janna N de Boer, et al.
Scientific Reports
|
April 9, 2021
Fragmented sleep relates to hallucinations across perceptual modalities in the general population
Sanne G Brederoo, Janna N de Boer, Jacqueline de Vries, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
March 12, 2024
The experience of felt presence in a general population sample
Sanne G Brederoo, Ben Alderson-Day, Janna N de Boer, et al.
Schizophrenia Bulletin
|
April 28, 2023
The Direct and Long-Term Effects of Raloxifene as Adjunctive Treatment for Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Clinical Trial
Bodyl A Brand, Janna N de Boer, Machteld C Marcelis, et al.
Page
of 3